The global Bronchiectasis Therapeutic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Bronchiectasis Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchiectasis Therapeutic.

Report Scope

The Bronchiectasis Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bronchiectasis Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bronchiectasis Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bronchiectasis Therapeutic Market Report

Report Metric	Details
Report Name	Bronchiectasis Therapeutic Market
CAGR	5%
Segment by Type	Antibiotics Expectorants Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Alitair Pharmaceuticals Inc., Bayer AG, Chiesi Farmaceutici SpA, Grifols SA, Insmed Inc, Kamada Ltd, Polyphor Ltd, Recipharm AB
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bronchiectasis Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bronchiectasis Therapeutic Market report?

Ans: The main players in the Bronchiectasis Therapeutic Market are GlaxoSmithKline, Alitair Pharmaceuticals Inc., Bayer AG, Chiesi Farmaceutici SpA, Grifols SA, Insmed Inc, Kamada Ltd, Polyphor Ltd, Recipharm AB

What are the Application segmentation covered in the Bronchiectasis Therapeutic Market report?

Ans: The Applications covered in the Bronchiectasis Therapeutic Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Bronchiectasis Therapeutic Market report?

Ans: The Types covered in the Bronchiectasis Therapeutic Market report are Antibiotics, Expectorants, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bronchiectasis Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Antibiotics

1.2.3 Expectorants

1.2.4 Others

1.3 Market by Application

1.3.1 Global Bronchiectasis Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bronchiectasis Therapeutic Market Perspective (2019-2030)

2.2 Bronchiectasis Therapeutic Growth Trends by Region

2.2.1 Global Bronchiectasis Therapeutic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Bronchiectasis Therapeutic Historic Market Size by Region (2019-2024)

2.2.3 Bronchiectasis Therapeutic Forecasted Market Size by Region (2025-2030)

2.3 Bronchiectasis Therapeutic Market Dynamics

2.3.1 Bronchiectasis Therapeutic Industry Trends

2.3.2 Bronchiectasis Therapeutic Market Drivers

2.3.3 Bronchiectasis Therapeutic Market Challenges

2.3.4 Bronchiectasis Therapeutic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bronchiectasis Therapeutic Players by Revenue

3.1.1 Global Top Bronchiectasis Therapeutic Players by Revenue (2019-2024)

3.1.2 Global Bronchiectasis Therapeutic Revenue Market Share by Players (2019-2024)

3.2 Global Bronchiectasis Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Bronchiectasis Therapeutic Revenue

3.4 Global Bronchiectasis Therapeutic Market Concentration Ratio

3.4.1 Global Bronchiectasis Therapeutic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Therapeutic Revenue in 2023

3.5 Bronchiectasis Therapeutic Key Players Head office and Area Served

3.6 Key Players Bronchiectasis Therapeutic Product Solution and Service

3.7 Date of Enter into Bronchiectasis Therapeutic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Bronchiectasis Therapeutic Breakdown Data by Type

4.1 Global Bronchiectasis Therapeutic Historic Market Size by Type (2019-2024)

4.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Type (2025-2030)

5 Bronchiectasis Therapeutic Breakdown Data by Application

5.1 Global Bronchiectasis Therapeutic Historic Market Size by Application (2019-2024)

5.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Bronchiectasis Therapeutic Market Size (2019-2030)

6.2 North America Bronchiectasis Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Bronchiectasis Therapeutic Market Size by Country (2019-2024)

6.4 North America Bronchiectasis Therapeutic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bronchiectasis Therapeutic Market Size (2019-2030)

7.2 Europe Bronchiectasis Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Bronchiectasis Therapeutic Market Size by Country (2019-2024)

7.4 Europe Bronchiectasis Therapeutic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Bronchiectasis Therapeutic Market Size (2019-2030)

8.2 Asia-Pacific Bronchiectasis Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2019-2024)

8.4 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Bronchiectasis Therapeutic Market Size (2019-2030)

9.2 Latin America Bronchiectasis Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Bronchiectasis Therapeutic Market Size by Country (2019-2024)

9.4 Latin America Bronchiectasis Therapeutic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bronchiectasis Therapeutic Market Size (2019-2030)

10.2 Middle East & Africa Bronchiectasis Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2019-2024)

10.4 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Bronchiectasis Therapeutic Introduction

11.1.4 GlaxoSmithKline Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.1.5 GlaxoSmithKline Recent Development

11.2 Alitair Pharmaceuticals Inc.

11.2.1 Alitair Pharmaceuticals Inc. Company Detail

11.2.2 Alitair Pharmaceuticals Inc. Business Overview

11.2.3 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Introduction

11.2.4 Alitair Pharmaceuticals Inc. Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.2.5 Alitair Pharmaceuticals Inc. Recent Development

11.3 Bayer AG

11.3.1 Bayer AG Company Detail

11.3.2 Bayer AG Business Overview

11.3.3 Bayer AG Bronchiectasis Therapeutic Introduction

11.3.4 Bayer AG Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.3.5 Bayer AG Recent Development

11.4 Chiesi Farmaceutici SpA

11.4.1 Chiesi Farmaceutici SpA Company Detail

11.4.2 Chiesi Farmaceutici SpA Business Overview

11.4.3 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Introduction

11.4.4 Chiesi Farmaceutici SpA Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.4.5 Chiesi Farmaceutici SpA Recent Development

11.5 Grifols SA

11.5.1 Grifols SA Company Detail

11.5.2 Grifols SA Business Overview

11.5.3 Grifols SA Bronchiectasis Therapeutic Introduction

11.5.4 Grifols SA Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.5.5 Grifols SA Recent Development

11.6 Insmed Inc

11.6.1 Insmed Inc Company Detail

11.6.2 Insmed Inc Business Overview

11.6.3 Insmed Inc Bronchiectasis Therapeutic Introduction

11.6.4 Insmed Inc Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.6.5 Insmed Inc Recent Development

11.7 Kamada Ltd

11.7.1 Kamada Ltd Company Detail

11.7.2 Kamada Ltd Business Overview

11.7.3 Kamada Ltd Bronchiectasis Therapeutic Introduction

11.7.4 Kamada Ltd Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.7.5 Kamada Ltd Recent Development

11.8 Polyphor Ltd

11.8.1 Polyphor Ltd Company Detail

11.8.2 Polyphor Ltd Business Overview

11.8.3 Polyphor Ltd Bronchiectasis Therapeutic Introduction

11.8.4 Polyphor Ltd Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.8.5 Polyphor Ltd Recent Development

11.9 Recipharm AB

11.9.1 Recipharm AB Company Detail

11.9.2 Recipharm AB Business Overview

11.9.3 Recipharm AB Bronchiectasis Therapeutic Introduction

11.9.4 Recipharm AB Revenue in Bronchiectasis Therapeutic Business (2019-2024)

11.9.5 Recipharm AB Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GlaxoSmithKline PLC

Alitair Pharmaceuticals Inc

Bayer

Chiesi Farmaceutici SpA

List of Tables

Table 1. Global Bronchiectasis Therapeutic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Antibiotics

Table 3. Key Players of Expectorants

Table 4. Key Players of Others

Table 5. Global Bronchiectasis Therapeutic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Bronchiectasis Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Bronchiectasis Therapeutic Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Bronchiectasis Therapeutic Market Share by Region (2019-2024)

Table 9. Global Bronchiectasis Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Bronchiectasis Therapeutic Market Share by Region (2025-2030)

Table 11. Bronchiectasis Therapeutic Market Trends

Table 12. Bronchiectasis Therapeutic Market Drivers

Table 13. Bronchiectasis Therapeutic Market Challenges

Table 14. Bronchiectasis Therapeutic Market Restraints

Table 15. Global Bronchiectasis Therapeutic Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Bronchiectasis Therapeutic Market Share by Players (2019-2024)

Table 17. Global Top Bronchiectasis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Therapeutic as of 2023)

Table 18. Ranking of Global Top Bronchiectasis Therapeutic Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Bronchiectasis Therapeutic Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Bronchiectasis Therapeutic Product Solution and Service

Table 22. Date of Enter into Bronchiectasis Therapeutic Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Bronchiectasis Therapeutic Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2019-2024)

Table 26. Global Bronchiectasis Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2025-2030)

Table 28. Global Bronchiectasis Therapeutic Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Bronchiectasis Therapeutic Revenue Market Share by Application (2019-2024)

Table 30. Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Bronchiectasis Therapeutic Revenue Market Share by Application (2025-2030)

Table 32. North America Bronchiectasis Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Bronchiectasis Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Bronchiectasis Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Bronchiectasis Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Bronchiectasis Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Bronchiectasis Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Bronchiectasis Therapeutic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Bronchiectasis Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Bronchiectasis Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Bronchiectasis Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Bronchiectasis Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 47. GlaxoSmithKline Company Detail

Table 48. GlaxoSmithKline Business Overview

Table 49. GlaxoSmithKline Bronchiectasis Therapeutic Product

Table 50. GlaxoSmithKline Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 51. GlaxoSmithKline Recent Development

Table 52. Alitair Pharmaceuticals Inc. Company Detail

Table 53. Alitair Pharmaceuticals Inc. Business Overview

Table 54. Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Product

Table 55. Alitair Pharmaceuticals Inc. Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 56. Alitair Pharmaceuticals Inc. Recent Development

Table 57. Bayer AG Company Detail

Table 58. Bayer AG Business Overview

Table 59. Bayer AG Bronchiectasis Therapeutic Product

Table 60. Bayer AG Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 61. Bayer AG Recent Development

Table 62. Chiesi Farmaceutici SpA Company Detail

Table 63. Chiesi Farmaceutici SpA Business Overview

Table 64. Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Product

Table 65. Chiesi Farmaceutici SpA Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 66. Chiesi Farmaceutici SpA Recent Development

Table 67. Grifols SA Company Detail

Table 68. Grifols SA Business Overview

Table 69. Grifols SA Bronchiectasis Therapeutic Product

Table 70. Grifols SA Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 71. Grifols SA Recent Development

Table 72. Insmed Inc Company Detail

Table 73. Insmed Inc Business Overview

Table 74. Insmed Inc Bronchiectasis Therapeutic Product

Table 75. Insmed Inc Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 76. Insmed Inc Recent Development

Table 77. Kamada Ltd Company Detail

Table 78. Kamada Ltd Business Overview

Table 79. Kamada Ltd Bronchiectasis Therapeutic Product

Table 80. Kamada Ltd Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 81. Kamada Ltd Recent Development

Table 82. Polyphor Ltd Company Detail

Table 83. Polyphor Ltd Business Overview

Table 84. Polyphor Ltd Bronchiectasis Therapeutic Product

Table 85. Polyphor Ltd Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 86. Polyphor Ltd Recent Development

Table 87. Recipharm AB Company Detail

Table 88. Recipharm AB Business Overview

Table 89. Recipharm AB Bronchiectasis Therapeutic Product

Table 90. Recipharm AB Revenue in Bronchiectasis Therapeutic Business (2019-2024) & (US$ Million)

Table 91. Recipharm AB Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Bronchiectasis Therapeutic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Bronchiectasis Therapeutic Market Share by Type: 2023 VS 2030

Figure 3. Antibiotics Features

Figure 4. Expectorants Features

Figure 5. Others Features

Figure 6. Global Bronchiectasis Therapeutic Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Bronchiectasis Therapeutic Market Share by Application: 2023 VS 2030

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Bronchiectasis Therapeutic Report Years Considered

Figure 12. Global Bronchiectasis Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Bronchiectasis Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Bronchiectasis Therapeutic Market Share by Region: 2023 VS 2030

Figure 15. Global Bronchiectasis Therapeutic Market Share by Players in 2023

Figure 16. Global Top Bronchiectasis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Therapeutic as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Bronchiectasis Therapeutic Revenue in 2023

Figure 18. North America Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Bronchiectasis Therapeutic Market Share by Country (2019-2030)

Figure 20. United States Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Bronchiectasis Therapeutic Market Share by Country (2019-2030)

Figure 24. Germany Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Bronchiectasis Therapeutic Market Share by Region (2019-2030)

Figure 32. China Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Bronchiectasis Therapeutic Market Share by Country (2019-2030)

Figure 40. Mexico Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Bronchiectasis Therapeutic Market Share by Country (2019-2030)

Figure 44. Turkey Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Bronchiectasis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. GlaxoSmithKline Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 47. Alitair Pharmaceuticals Inc. Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 48. Bayer AG Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 49. Chiesi Farmaceutici SpA Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 50. Grifols SA Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 51. Insmed Inc Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 52. Kamada Ltd Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 53. Polyphor Ltd Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 54. Recipharm AB Revenue Growth Rate in Bronchiectasis Therapeutic Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions